ATryn® Antithrombin (Recombinant) is the first and only plasma-free antithrombin concentrate. ATryn also holds the distinction of being the first product developed using rPRO Technology — a more natural, scalable and cost-effective method of protein production.
ATryn received FDA approval in 2009, and marketing authorization by the European Commission prior to that in 2006.
Comprehensive Distributor Network
ATryn is available through the following distributors, who should be contacted directly for product ordering.
Cardinal Health SPD
FFF Enterprises, Inc.
McKesson Plasma and BioLogics, LLC
National Hospital Specialties (NHS)
Novis Pharmaceuticals, LLC